Download Docs
Export

Novel T-Cell Redirecting Anti-CD19-F(ab)2/CD3scFv Bispecific Antibody Exhibits Potent Lymphoma Cytotoxicity

61/682,965 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Location ELECTRONIC
Filed Aug. 14, 2012
Case Type Provisional
Status Provisional Application Expired
Child 13/966,450 Patented
Child PCT/US13/54842 Published
Child 15/62,919 Abandoned
Child 15/64,128 Patented
Child 15/289,357 Patented
Child 15/590,514 Patented
Show All
Last Updated: 1 year, 11 months ago
Date # Transaction